免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

The Evaluation of Safety and Myopia Progression Control Using Novel Spectacle Lens

NCT:NCT05886348 · ACTIVE_NOT_RECRUITING

NCT IDNCT05886348
狀態ACTIVE_NOT_RECRUITING
開始日期2023-07-31
完成時間2027-05-31
SponsorHOYA Lens Thailand LTD. (INDUSTRY)
First posted
Last updated

簡要摘要

The goal of this clinical trial is to test Novel spectacle lenses in myopic children. The main question it aims to answer are: safety and efficacy of the lenses. Participants will be asked to wear spectacles and participate in eye exams and questionnaires. Researchers will compare Novel spectacle lenses and general single vision spectacle lenses to see if the Novel spectacle lenses correct myopic ametropia, slow the progression of myopia and axial elongation.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑